There is a mountain of evidence to support that a high body mass index (BMI) and obesity negatively impact cancers, diabetes, cardiovascular, and other diseases. Yet, for every “rule” there is always an exception and investigators at Flinders University in South Australia, have found that in some cases a high BMI may actually improve the chance of survival among certain cancers. Focusing on clinical trials of atezolizumab, a common immunotherapy treatment for non-small-cell lung cancer (NSCLC), the research team found improved responsiveness to the drug in those with a high BMI.
Image: https://www.genengnews.com
